Opinion on the impact of non‐monotonic dose responses on EFSA′s human health risk assessments
Abstract This Opinion assesses the biological relevance of the non‐monotonic dose responses (NMDR) identified in a previous EFSA External Report (Beausoleil et al., 2016) produced under GP/EFSA/SCER/2014/01 and the follow‐up probabilistic assessment (Chevillotte et al., 2017a,b), focusing on the in ...
Guardado en:
Autores principales: | EFSA Scientific Committee, Simon More, Diane Benford, Susanne Hougaard Bennekou, Vasileios Bampidis, Claude Bragard, Thorhallur Halldorsson, Antonio Hernandez‐Jerez, Kostas Koutsoumanis, Claude Lambré, Kyriaki Machera, Ewen Mullins, Søren Saxmose Nielsen, Josef Schlatter, Dieter Schrenk, Dominique Turck, Jose Tarazona, Maged Younes |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Wiley
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/71f15f72c9644c07a79127ec9b5b2233 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
- EFSA journal
-
Additional baricitinib loading dose improves clinical outcome in COVID-19
por: Hasan Md Jahidul, et al.
Publicado: (2020) -
Correlation between Serum Zinc Levels and Levodopa in Parkinson’s Disease
por: Hirofumi Matsuyama, et al.
Publicado: (2021) -
Margin of Exposure Analyses and Overall Toxic Effects of Alcohol with Special Consideration of Carcinogenicity
por: Alex O. Okaru, et al.
Publicado: (2021) -
Bioequivalence and food effect of a fixed‐dose combination of macitentan and tadalafil: Adaptive design in the COVID‐19 pandemic
por: Dénes Csonka, et al.
Publicado: (2021)